Testosterone Suppression Plus Enzalutamide Versus Testosterone Suppression Plus Standard Antiandrogen Therapy for Metastatic Hormone-Sensitive Prostate Cancer (ENZAMET): an International, Open-Label, Randomised, Phase 3 TrialChristopher J. Sweeney,Andrew J. Martin,Martin R. Stockler,Stephen Begbie,Leanna Cheung,Kim N. Chi,Simon Chowdhury,Mark Frydenberg,Lisa G. Horvath,Anthony M. Joshua,Nicola J. Lawrence,Gavin Marx,John McCaffrey,Ray McDermott,Margaret McJannett,Scott A. North,Francis Parnis,Wendy Parulekar,David W. Pook,Martin Neil Reaume,Shahneen K. Sandhu,Alvin Tan,Thean Hsiang Tan,Alastair Thomson,Francisco Vera-Badillo,Scott G. Williams, Diana Winter,Sonia Yip,Alison Y. Zhang,Robert R. Zielinski,Ian DavisLANCET ONCOLOGY（2023）引用 29|浏览50关键词testosterone suppression,standard antiandrogen therapy,prostate,hormone-sensitive,open-labelAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
